HLE Glascoat LtdQ3 FY23Industrial Manufacturing

HLE Glascoat Ltd

Q3 FY23 Earnings Call Analysis

Management growth scorecard

Revenue

Category 3

Margin

Category 3

Fundraise

Order

Capex

0 of 5 growth signals are positive — mixed outlook.

Full analysis

Revenue guidance

Category 3

→The company anticipates growth driven by strong order books and pipeline, especially from the pharma and USA markets.
→Introduction of Thaletec products in India has been positive, with confirmed orders and good initial response, opening newer opportunities without cannibalizing existing markets.
→The API pharma segment's share, currently around 40%, is expected to increase over the next few years, possibly returning towards historical levels of 55-60%.
→The second half of the financial year generally contributes 55-60% of revenues, with expectations to catch up on deferred orders from first half.
→No major new capex projects planned for FY25; focus on maintaining and leveraging existing capacities.
→Margins in glassline business expected to normalize at 16-18% long-term sustainable levels, supporting revenue growth in a normalized market environment.

Margin guidance

Category 3

→The company expects steady revenue growth aided by the recent acquisition of Kinam Engineering Industries, expanding the product portfolio and incorporating new technology.
→Filtration, drying, and other equipment segments grew 22.2% YoY, with plans for normal maintenance capex of INR 8-10 crores annually, indicating stable expansion.
→Thaletec reactors launch in India has been received positively, with confirmed orders contributing to revenue and expectations of sustaining EBITDA margins of 16% to 18%.
→The pharmaceutical (API) sector share, currently at ~40%, is expected to grow in coming years, supporting future order book growth.
→Domestic glassline business margins are projected to stabilize around 16%-18%, down from volatile past highs but sustainable.
→Operating leverage from higher revenue will help improve margins.
→Promoters plan to maintain a healthy stake, indicating confidence in long-term growth.
→Overall, the company anticipates resilient earnings growth driven by product diversification, market expansion, and improved operational efficiencies.

Get access to all 5 sections — revenue, margin, fundraise, orderbook, and capex — for HLE Glascoat Ltd and 1,400+ other companies.

Fundraise plans

- There is no indication of any current or planned reduction of promoter stakes beyond the recent strategic investor inclusion, which was aimed at bringing a high-quality investor without reducing promoter holdings significantly. - There is no mention of any new fundraising through equity in the transcript; the focus was on issuing shares to erstwhile promoters of Kinam as part of acquisition consideration, not new equity raise. - Regarding debt, the company has highlighted significant cash flow available for debt repayment in the next year, implying a focus on deleveraging rather than raising new debt. - Capex plans for FY25 are limited to normal maintenance capex (~INR 8-10 crores), with no major new investments requiring additional fundraising. Overall, no clear plans for fresh fundraising through either debt or equity were disclosed in the call.

Order book

→Current order book provides about five months of visibility for the India business.
→Thaletec Germany business has a visibility of 9 to 10 months.
→The business in the USA is described as encouraging with a strong order pipeline.
→The company is experiencing a varied market: agrochemical segment is muted with deferred orders, specialty chemicals and pharmaceutical sectors showing stronger order flows.
→Overall, the order book reflects resilience and a strong pipeline of inquiries, especially from pharma sectors.
→Order book composition and demand are evolving, with pharma expected to increase its share over time.
→The company continues to manufacture based on confirmed orders, leading to inventory fluctuations aligned with order flow.

Capex plans

→No major new capex projects are currently planned.
→Normal maintenance capex is expected in the range of INR 8 crores to INR 10 crores annually.
→No new products are planned that would require additional capital expenditure.
→The company will invest INR 77.5 crores to acquire the balance 34.44% stake in Kinam Engineering Industries, increasing their holding to 70%. This payment will be made through share issuance, so there is no cash outflow.
→The INR 230 crores recorded represents the value of 100% purchase of Kinam's property, plant, and equipment; no additional capex for plant and machinery purchase is anticipated.
→Overall, capital investments focus on strategic acquisitions and maintenance rather than expansion or new product development.

How does HLE Glascoat Ltd rank vs peers in Industrial Manufacturing?

Pro feature

1HLE Glascoat Ltd

Rev 3Mar 3

See full Industrial Manufacturing sector rankings

Unlock with Pro

Want more stocks like HLE Glascoat Ltd?

Build an AI portfolio filtered by sector, market cap, and growth rank. Takes 2 minutes.

Build my portfolio